デフォルト表紙
市場調査レポート
商品コード
1604696

人工涙液市場:製品タイプ、用途、送達モード別-2025-2030年の世界予測

Artificial Tears Market by Product Type (Cellulose-derived, Glycerin-derived, Oil-based Emulsion), Application (Contact Lens Moisture, Dry Eye Treatment), Delivery Mode - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 187 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
人工涙液市場:製品タイプ、用途、送達モード別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 187 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

人工涙液市場は、2023年に20億6,000万米ドルと評価され、2024年には22億3,000万米ドルに達すると予測され、CAGR 8.27%で成長し、2030年には36億米ドルに達すると予測されています。

人工涙液市場は、主に目の乾燥や炎症を緩和するために使用される、目の潤滑と水分補給を目的とした製品に焦点を当てています。人工涙液の必要性は、ドライアイ症候群、長時間のスクリーン使用、加齢、環境要因などの様々な条件から生じる。人工涙液の用途は、単なる目の水分補給にとどまらず、手術後のケアやコンタクトレンズ使用者の視覚的快適性の向上などにも広がっています。エンドユーザーは個人消費者からヘルスケア施設までと幅広く、小売業や医療分野など幅広い範囲をカバーしています。主な成長要因としては、眼精疲労につながるデジタル機器の使用の増加、ドライアイになりやすい高齢化人口の増加、防腐剤フリーのオプションや高度な送達システムなどの製品処方の革新などが挙げられます。最近のビジネスチャンスは、目の健康に対する意識の高まりや、一般用医薬品(OTC)製品に対する需要の増加から生じており、小売店やeコマース・チャンネルにおけるブランドの存在感を高める必要性が強調されています。

主な市場の統計
基準年[2023] 20億6,000万米ドル
推定年[2024] 22億3,000万米ドル
予測年[2030] 36億米ドル
CAGR(%) 8.27%

しかし、市場成長は、消費者の信頼に影響を与える製品回収事件や、医療製品を管理する厳しい規制のハードルといった課題に直面しています。また、既存製薬企業との競合やブランド・ロイヤルティも大きな障壁となっています。イノベーションの機会は、多機能人工涙液の開発、環境に優しいパッケージング、AIを利用したパーソナライズされたアイケアソリューションなどの分野で熟しています。したがって、企業は新規処方の研究開発に投資し、デジタルマーケティングを活用してハイテクに詳しい消費者を取り込むべきです。さらに、ヘルスケアプロバイダーとの提携により、流通網を強化することができます。規制状況や消費者行動の地域差を理解することは、市場浸透戦略の最適化に不可欠です。市場は現在、北米とアジア太平洋地域の成長に焦点を当てた消費者主導型であるが、戦略的な地理的拡大とテクノロジーへの投資を組み合わせることで、将来の成長見通しを拡大することができます。企業は、固有の課題に対処しながら市場機会を十分に活用するために、持続可能性の動向に合わせ、目の健康に関する消費者教育を優先させる必要があります。

市場力学:急速に進化する人工涙液市場の主要市場インサイトを公開

人工涙液市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 世界の眼障害の増加
    • ドライアイ症候群の有病率の増加
    • 早期診断・早期治療への意識の高まり
  • 市場抑制要因
    • 人工涙液の短期的効果
  • 市場機会
    • 安定性を高めた改良型人工涙液のイントロダクション
    • 革新的な人工涙液製剤の開発に向けた多額の投資
  • 市場の課題
    • 汚染された人工涙液の使用に関するリスク

ポーターのファイブフォース:人工涙液市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:人工涙液市場における外部からの影響の把握

外部マクロ環境要因は、人工涙液市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析人工涙液市場における競合情勢の把握

人工涙液市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス人工涙液市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、人工涙液市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨人工涙液市場における成功への道筋を描く

人工涙液市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で眼疾患の発生率が上昇
      • ドライアイ症候群の罹患率の増加
      • 早期診断と治療への意識と傾向の高まり
    • 抑制要因
      • 人工涙液の短期的な影響
    • 機会
      • 安定性を強化した改良版人工涙液のイントロダクション
      • 革新的な人工涙液製剤の開発への多額の投資
    • 課題
      • 汚染された人工涙液の使用に関連するリスク
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 人工涙液市場:製品タイプ別

  • セルロース由来
  • グリセリン由来
  • 油性エマルジョン
  • ポリエチレングリコールベース
  • プロピレングリコールベース
  • ヒアルロン酸ナトリウムベース

第7章 人工涙液市場:用途別

  • コンタクトレンズの水分
  • ドライアイ治療

第8章 人工涙液市場配送方法別

  • 目薬
  • 軟膏

第9章 南北アメリカの人工涙液市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の人工涙液市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの人工涙液市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • AbbVie Inc.
  • Alcon Vision LLC
  • Bausch & Lomb Incorporated
  • Bayer AG
  • Horus Pharma
  • Johnson & Johnson Services, Inc.
  • Nicox S.A.
  • Novartis AG
  • Novax Pharma
  • Oasis Medical, Inc.
  • OCuSOFT Inc.
  • OmniVision GmbH
  • Otsuka Pharmaceutical Co., Ltd.
  • Prestige Consumer Healthcare Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Scope Ophthalmics Ltd.
  • Shire PLC by Takeda Pharmaceutical Company Limited
  • Similasan Corporation
  • Sun Pharmaceutical Industries, Inc.
  • Taiwan Biotech Co., Ltd.
  • Thea Pharmaceuticals Ltd.
  • URSAPHARM Arzneimittel GmbH
  • Visufarma
  • ZEISS Group
図表

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL TEARS MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL TEARS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL TEARS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ARTIFICIAL TEARS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ARTIFICIAL TEARS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL TEARS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL TEARS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL TEARS MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CELLULOSE-DERIVED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY GLYCERIN-DERIVED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OIL-BASED EMULSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY POLYETHYLENE GLYCOL-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PROPYLENE GLYCOL-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SODIUM HYALURONATE-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CONTACT LENS MOISTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DRY EYE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ARTIFICIAL TEARS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ARTIFICIAL TEARS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 147. ARTIFICIAL TEARS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. ARTIFICIAL TEARS MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-69324464D1AA

The Artificial Tears Market was valued at USD 2.06 billion in 2023, expected to reach USD 2.23 billion in 2024, and is projected to grow at a CAGR of 8.27%, to USD 3.60 billion by 2030.

The artificial tears market focuses on products designed to lubricate and hydrate the eyes, primarily used to alleviate dryness and irritation. The necessity for artificial tears arises from various conditions such as dry eye syndrome, prolonged screen time, aging, and environmental factors. Applications of artificial tears are expanding beyond mere eye hydration to include post-surgery care and enhanced visual comfort for contact lens users. End users range from individual consumers to healthcare facilities, providing broad scope across retail and medical sectors. Key growth influencers include increasing digital device usage leading to eye strain, a growing aging population more susceptible to dry eye conditions, and innovations in product formulations, like preservative-free options and advanced delivery systems. Recent opportunities stem from the rise in awareness about eye health and increased demand for over-the-counter (OTC) products, emphasizing the need for brands to enhance presence in retail and e-commerce channels.

KEY MARKET STATISTICS
Base Year [2023] USD 2.06 billion
Estimated Year [2024] USD 2.23 billion
Forecast Year [2030] USD 3.60 billion
CAGR (%) 8.27%

However, market growth faces challenges such as product recall incidents affecting consumer trust and stringent regulatory hurdles governing medical products. Competition from established pharmaceutical companies and brand loyalty also pose significant barriers. Innovation opportunities are ripe in areas like developing multifunctional artificial tears, eco-friendly packaging, and personalized eye care solutions using AI. Thus, companies should invest in R&D for novel formulations and leverage digital marketing to captivate tech-savvy consumers. Additionally, partnerships with healthcare providers can enhance distribution networks. Understanding regional variances in regulatory landscapes and consumer behaviors is vital for optimizing market penetration strategies. While the market is currently consumer-driven with a growth focus in North America and Asia-Pacific regions, strategic geographic expansions, coupled with investments in technology, can amplify future growth prospects. Businesses must align with sustainability trends and prioritize consumer education about eye health to fully capitalize on market opportunities while addressing inherent challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Tears Market

The Artificial Tears Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of eye disorders worldwide
    • Increasing prevalence of dry eye syndrome
    • Growing awareness and inclination towards early diagnosis and treatment
  • Market Restraints
    • Short-term effects of artificial tears
  • Market Opportunities
    • Introduction of improved artificial tears with enhanced stability
    • Significant investments in developing innovative artificial tear formulations
  • Market Challenges
    • Risk pertaining to the use of contaminated artificial tears

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Tears Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Tears Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Tears Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Tears Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Tears Market

A detailed market share analysis in the Artificial Tears Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Tears Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Tears Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Tears Market

A strategic analysis of the Artificial Tears Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Tears Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Vision LLC, Bausch & Lomb Incorporated, Bayer AG, Horus Pharma, Johnson & Johnson Services, Inc., Nicox S.A., Novartis AG, Novax Pharma, Oasis Medical, Inc., OCuSOFT Inc., OmniVision GmbH, Otsuka Pharmaceutical Co., Ltd., Prestige Consumer Healthcare Inc., Santen Pharmaceutical Co., Ltd., Scope Ophthalmics Ltd., Shire PLC by Takeda Pharmaceutical Company Limited, Similasan Corporation, Sun Pharmaceutical Industries, Inc., Taiwan Biotech Co., Ltd., Thea Pharmaceuticals Ltd., URSAPHARM Arzneimittel GmbH, Visufarma, and ZEISS Group.

Market Segmentation & Coverage

This research report categorizes the Artificial Tears Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cellulose-derived, Glycerin-derived, Oil-based Emulsion, Polyethylene Glycol-based, Propylene Glycol-based, and Sodium Hyaluronate-based.
  • Based on Application, market is studied across Contact Lens Moisture and Dry Eye Treatment.
  • Based on Delivery Mode, market is studied across Eye Drops and Ointments.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of eye disorders worldwide
      • 5.1.1.2. Increasing prevalence of dry eye syndrome
      • 5.1.1.3. Growing awareness and inclination towards early diagnosis and treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Short-term effects of artificial tears
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of improved artificial tears with enhanced stability
      • 5.1.3.2. Significant investments in developing innovative artificial tear formulations
    • 5.1.4. Challenges
      • 5.1.4.1. Risk pertaining to the use of contaminated artificial tears
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Tears Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cellulose-derived
  • 6.3. Glycerin-derived
  • 6.4. Oil-based Emulsion
  • 6.5. Polyethylene Glycol-based
  • 6.6. Propylene Glycol-based
  • 6.7. Sodium Hyaluronate-based

7. Artificial Tears Market, by Application

  • 7.1. Introduction
  • 7.2. Contact Lens Moisture
  • 7.3. Dry Eye Treatment

8. Artificial Tears Market, by Delivery Mode

  • 8.1. Introduction
  • 8.2. Eye Drops
  • 8.3. Ointments

9. Americas Artificial Tears Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Artificial Tears Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Artificial Tears Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Alcon Vision LLC
  • 3. Bausch & Lomb Incorporated
  • 4. Bayer AG
  • 5. Horus Pharma
  • 6. Johnson & Johnson Services, Inc.
  • 7. Nicox S.A.
  • 8. Novartis AG
  • 9. Novax Pharma
  • 10. Oasis Medical, Inc.
  • 11. OCuSOFT Inc.
  • 12. OmniVision GmbH
  • 13. Otsuka Pharmaceutical Co., Ltd.
  • 14. Prestige Consumer Healthcare Inc.
  • 15. Santen Pharmaceutical Co., Ltd.
  • 16. Scope Ophthalmics Ltd.
  • 17. Shire PLC by Takeda Pharmaceutical Company Limited
  • 18. Similasan Corporation
  • 19. Sun Pharmaceutical Industries, Inc.
  • 20. Taiwan Biotech Co., Ltd.
  • 21. Thea Pharmaceuticals Ltd.
  • 22. URSAPHARM Arzneimittel GmbH
  • 23. Visufarma
  • 24. ZEISS Group